Low Libido in Women

What Is Low Libido in Women?

Low libido — or hypoactive sexual desire — is a persistent reduction in interest in sexual activity that causes personal distress. It’s one of the most common sexual health concerns reported by women, particularly during and after the perimenopausal transition.

While desire naturally fluctuates throughout life, a sustained loss of interest — especially when accompanied by physical symptoms like vaginal dryness or discomfort — often points to a hormonal root cause that responds well to treatment.

Common Symptoms

Low libido in women often coexists with other signs of hormonal change:

• Noticeably reduced interest in or initiation of sexual activity
• Difficulty becoming aroused even with adequate stimulation
• Vaginal dryness, thinning tissue, or discomfort during intimacy
• Reduced physical sensitivity or pleasure
• Emotional distance or feeling disconnected from a partner
• Fatigue or low energy that reduces motivation for intimacy

What Causes It?

Female sexual desire is influenced by a complex interplay of hormones, including estrogen, progesterone, and testosterone. Common hormonal causes include:

• Declining estrogen — Reduced estrogen during perimenopause and menopause leads to vaginal atrophy, dryness, and decreased blood flow to sexual tissues
• Low testosterone — Women produce testosterone too, and declining levels directly affect desire and arousal
• Progesterone changes — Fluctuating progesterone can affect mood, energy, and receptivity
• Elevated cortisol — Chronic stress suppresses sex hormones and reduces desire
• Thyroid dysfunction — Hypothyroidism reduces overall vitality and sexual interest
• Medications — Antidepressants (particularly SSRIs), hormonal contraceptives, and blood pressure medications commonly affect libido

How BHRT Can Help

At BHRT Boost, treatment for low libido begins with a comprehensive lab panel evaluating estradiol, progesterone, total and free testosterone, DHEA-S, thyroid markers, and cortisol. Understanding the full hormonal landscape is essential because libido issues rarely have a single cause.

Treatment may include:

• Bioidentical testosterone at physiological doses to directly support desire and arousal
• Estradiol therapy to restore vaginal tissue health, lubrication, and blood flow
• Progesterone support for mood, sleep, and overall hormonal balance
• Thyroid or adrenal optimization when contributing dysfunction is identified

The goal is to address every hormonal factor contributing to reduced desire — not just one hormone in isolation.

What to Expect From Treatment

Many women notice improvements in comfort and desire within the first month of beginning bioidentical therapy. Vaginal dryness and tissue changes often improve within two to four weeks with estrogen support. Full restoration of libido and sexual satisfaction typically develops over two to three months as all hormone levels reach optimal ranges.

Your provider monitors your response through follow-up labs and check-ins, adjusting your protocol to achieve the best possible outcome.